Brookwood Investment Group »

Oruka Therapeutics shares owned by Brookwood Investment Group

Quarter-by-quarter ownership of Oruka Therapeutics (ORKA) shares owned by Brookwood Investment Group from 13F filings

Historical chart of Brookwood Investment Group investment in Oruka Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oruka Therapeutics held by Brookwood Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oruka Therapeutics by Brookwood Investment Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $502k 17k 30.31

More positions owned by Brookwood Investment Group

NVIDIA Corporation (NVDA)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds Growth Etf (VUG)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Alphabet Cap Stk Cl A (GOOGL)
Morgan Stanley Etf Trust Eaton Vance Mort (EVMO)
Etf Ser Solutions Aptus Defined (DRSK)
Invesco Exch Traded Fd Tr Ii S&p 500 Momntm (SPMO)
Tidal Trust I Fundstrat Granny (GRNY)
Tcw Etf Trust Flexible Income (FLXR)
Pimco Etf Tr Multisector Bd (PYLD)

View all positions for Brookwood Investment Group

Top funds holding Oruka Therapeutics

FMR
VR Adviser
Fairmount Funds Management
BlackRock
Viking Global Investors
Vanguard Group
Deep Track Capital
Rtw Investments
Commodore Capital
Paradigm Biocapital Advisors
State Street Corporation
venBio Select Advisor
Perceptive Advisors
Polar Capital Holdings
Geode Capital Management

View all funds holding Oruka Therapeutics